Stock 600380 JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Joincare Pharmaceutical Group Industry Co.,Ltd.

Equities

600380

CNE000001816

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
11.67 CNY -0.17% Intraday chart for Joincare Pharmaceutical Group Industry Co.,Ltd. +1.30% -6.11%
Apr. 18 Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint MT
Apr. 18 Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint
MT
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study
CI
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%
MT
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug
MT
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President
MT
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment
MT
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd
CI
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug
MT
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical
MT
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog
MT
Joincare Gets Nod to Trial Pain Relief Drug
MT
Joincare Pharma Shortlisted For China’s Drug Procurement Program
MT
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.
CI
Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.
CI
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug
MT
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.
CI
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Livzon Pharmaceutical Gets Nod to Register Blonanserin Tablets
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600380 Stock
  4. News Joincare Pharmaceutical Group Industry Co.,Ltd.